PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16860001-6	2006	Addition of TEMPOL caused a decrease in angiotensin II-induced contraction only in the patients" group.	tempol	12-18	angiotensinogen	Homo sapiens	40-54	
16243586-6	2005	Treatment with TEMPOL, human superoxide dismutase, diphenyleneiodonium, oxypurinol, NG-monomethyl L-arginine considerably decreased contractile response to angiotensin II in radial arteries.	tempol	15-21	angiotensinogen	Homo sapiens	156-170	
16151022-6	2005	Functionally, Ang II-elicited pressor response in the RVLM was attenuated by DPI, tempol, or a p38 MAPK inhibitor, SB203580.	tempol	82-88	angiotensinogen	Homo sapiens	14-20	
12595345-9	2003	Ang II-mediated inhibition was not observed in the presence of L-NMMA or after endothelial removal but was prevented by losartan, superoxide scavenger TEMPOL, or NADPH oxidase inhibitor apocynin.	tempol	151-157	angiotensinogen	Homo sapiens	0-6	
15746442-7	2005	Extracellular application of the ROS scavenger, Tempol, attenuated the Ang II-induced increase in neuronal firing rate by 70%.	tempol	48-54	angiotensinogen	Homo sapiens	71-77	
21210749-6	2011	The antioxidant agents tempol and diphenyleneiodonium (DPI) reverted the hyperreactivity to Ang II in HT rings.	tempol	23-29	angiotensinogen	Homo sapiens	92-98	
21210749-13	2011	With regard to resting membrane potential, we found in HT rings that the depolarization induced by Ang II was abolished by tempol.	tempol	123-129	angiotensinogen	Homo sapiens	99-105	
28203527-12	2016	Angiotensin II increased PKC activity in vehicle-treated cells that further increased in DETC-treated cells, which was attenuated by AT1R blocker candesartan and SOD-mimetic tempol.	tempol	174-180	angiotensinogen	Homo sapiens	0-14	
21270817-7	2011	Pretreatment with CV11974 (100 nM) or tempol (3 mM) abolished Ang II-induced astrocyte beta-galactosidase staining.	tempol	38-44	angiotensinogen	Homo sapiens	62-68	
20814019-6	2010	The Ang II-induced BDNF upregulation in RVLM was attenuated by coadministration of the NADPH oxidase inhibitor apocynin; the superoxide dismutase mimetic tempol; or an antisense oligonucleotide against CREB.	tempol	154-160	angiotensinogen	Homo sapiens	4-10	
19366904-9	2009	Use of 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (a superoxide dismutase mimetic) prevented both vasoconstriction with iodixanol alone and increased constriction with angiotensin II caused by CM.	tempol	7-53	angiotensinogen	Homo sapiens	172-186